Our Pharmaceutical Medicine Programme has proven to be the perfect springboards to fulfilling, life-changing careers.
The opportunities created due to the job rotations in our international environment provide you with a rapid growth in experience, the creation of huge networks across the organisation and an increased level of exposure to top management.
Together with the intensive professional and personal training available during the programme, this places you in a strong position to go on to be a key person within our organisation after successfully completing the pharmaceutical medicine programme.
And here's the proof! Read the stories below to discover how the ex-participants in our Pharmaceutical Medicine Programme have moved onwards and upwards within the organisation. You can also meet the PMP’s currently enrolled in the programme, and get some key insights into the life as an MD in the pharmaceutical industry.
The PMP team 2016 included Mikkel, Eskil, Azadeh, Joshua and Pam
Mikkel joined the PMP
after completing his clinical internship and a PhD wherein he
characterized of a novel peptide system in the gut and brain.
Upon completion of the programme, Mikkel joined the Semaglutide Obesity team in Global Medical Affairs as a Global Medical Manager
Eskil graduated from Medical School at the University of Copenhagen in 2010 after which he completed his internships and conducted research within genetics, immune mediated diseases and growth. Eskil completed a MSc within epidemiology and a PhD before joining the programme. Upon completion he took up a position as International Medical Manager in Medical and Science
Azadeh joined the programme upon completion of her clinical internship and a PhD within diabetes in pregnancy and offspring risk of metabolic disease.
She went on maternity leave after completing two out of three PMP rotations, and is scheduled to complete the programme in 2019.
Joshua and Pam both chose to pursue a career outside of Novo Nordisk, without completing the programme.
In 2015 the PMP team included Christin, Cristina, Melissa and Ting.
Christin joined the programme after completing internship and a PhD investigating the genetic background of young sudden cardiac death victims. She is now working as a Global Medical Advisor in Medical Affairs, Oral Semaglutide.
Cristina joined the programme after completing her medical training and speciality in Endocrinology in Italy. After successful completion of the programme Cristina decided to return to public health care system.
Melissa graduated from the University of Copenhagen in 2007, followed by some years of clinical experience, obtained a PhD combining oncology and chronobiology in 2014 and right before joining Novo Nordisk worked within the field of Clinical Pharmacology. After finalising the programme, Melissa joined Global Medical Affairs working as Global Medical Advisor in the Degludec/IDegLira team.
Ting graduated from Peking University in 2006 and completed her specialization in Nephrology later on. She joined the programme after completing her PhD within Nephrology and postdoc in Public Health. After the programme, she is now working as an Senior International Medical Manager in Global Development, Insulin & Devices.
In 2014 the PMP team included Marie, Cecilie, Sarah, Bue and Søren.
Marie joined the programme after completing internship and a PhD within neuroscience. After the programme, she now works as an International Medical Manager in Global Development, Obesity.
Cecilie joined the programme after several years of clinical experience within anaesthesiology, and after having completed a two-year research fellowship within inflammation and endotheliopathy at Harvard/MGH. Cecilie now works as a Global Medical Advisor in the Medical Affairs Obesity team and she is also the manager of the PMP.
Sarah has decided to pursue an adventure with her family and will be travelling for the next year to come.
Bue graduated from University of Copenhagen in 2007 and joined the programme with experience from internal medicine, cardiology and emergency medicine and a PhD in Cardiology. Bue now works as a Global Medical Advisor in Global Medical Affairs, IDegLira.
Søren joined the programme after working in the clinic within cardiology where he also obtained his PhD. After the PMP rotations, Søren continued in Global Development as International Medical Manager in Global Development, Semaglutide, Diabetes & Outcomes.
In 2013 the PMP team included Frida, Keval, Salvatore and Bo
Frida joined the programme after having worked in the clinical setting across various specialties and additional research experience. After the programme Frida worked as a Safety Surveillance Specialist in Global Safety and then left Novo Nordisk to pursue a PhD education.
Keval joined the PMP after completing his medical training in the UK. He also holds a PhD in the role of gut hormones in diabetes and obesity. After working in medical affairs as a Global Medical Advisor in the IDegLira team Keval is now a manager in Novo Nordisk Canada.
Salvatore joined the programme after completion of internal medicine residency He embarked on several years of research activities, mainly in pre-diabetes and type 2 diabetes, and completed his PhD at the University of Copenhagen. He now works as a Global Medical Advisor in Global Medical Affairs and is also a member of the PMP steering committee
Bo joined the programme after having specialised as a cardiac electrophysiologist and several years of research, including a PhD within cardiac arrhythmias. Bo now works in Global Development, M&S, Insulin & Digital Health as an International Medical Manager.
In 2012 the PMP team included Ditte, Veronica and Henrik.
Ditte joined the programme after obtaining a PhD within cardiology. She worked as an International Medical Manager in Global Development, M&S, Insulin & Digital Health and after a couple of years decided to continue her career within another pharmaceutical company.
Veronica, who prior to joining the programme worked in the clinic, conducted research, and obtained her PhD within insulin resistance and obesity. Veronica worked as a Safety Surveillance Specialist in Global Safety and after a couple of years left Novo Nordisk to work in another pharmaceutical company.
Henrik Jarlov joined the programme after several years in the clinic working with orthopaedic surgery. Henrik is now Director Medical Affairs and Science, working out of Dubai.
Henrik worked and researched within rheumatology before joining the programme. He chose to return to the public health care system after a year in the programme.
In 2011 the PMP team included Anne K, Anne Ø and Anders.
Anne K joined the program after internship and several years of research and a PhD within type 1 diabetes. After the PMP Anne worked asa Safety Surveillance Specialist in Global Safety for 2 years, before she joined Global Development as an International Medical Director. In addition, Anne was the manager of the PMP programme for 2 years.
Anne Ø finished her internship prior to joining the programme and
holds a bachelor degree within Business Administration. Anne now works
as an International Medical Manager in Global Development, M&S,
Insulin & Digital Health.
Anders Hvelplund, who prior to joining the programme worked in the clinic, conducted research, and completed his PhD within cardiology. After the PMP rotations, Anders continued in Global Development as Medical Specialist in the cardiovascular outcomes group working on the large cardiovascular outcomes trials DEVOTE and LEADER. He was appointed Medical Director in Medical & Science Semaglutide sc. and he is now working in Novo Nordisk Inc. (USA) as Executive Director Clinical Development, Diabetes & Obesity.
In 2010 the team included Ida, Anders and Florian.
Ida, finished her internship and worked in gastrointestinal and orthopaedic surgery before completing a PhD within the field of osteoarthritis. After having completed the programme Ida has worked in Global Safety prior as a Safety Surveillance Principal Specialist and now as Manager. In addition, Ida was the manager of the PMP programme during 2016.
Florian joined the programme after working with cardiology and nephrology in the clinic and has previously conducted research within neuroanatomy. Following the programme he joined Global Medical Affairs, where he headed up the Liraglutide Diabetes team as a Senior Global Medical Director for a couple of years and then has become Vice President in Global Medical Affairs.
Anders, who prior to joining the programme worked in the clinic, conducted research and completed a PhD within the field of rheumatology. Following the PMP programme Anders Anders held different positions within Global Development before he decided to pursue a career within another pharmaceutical company.
In 2009, the PMP team included Oscar, Claus and Jeppe.
Oscar worked and researched within cardiovascular medicine before joining the programme. After a couple of years he chose to return to the public health care system.
Claus previously worked in the clinic and conducted research within inflammation and chronic autoimmune diseases. After the program, he joined Global Medical Affairs, where he headed up the area of GLP-1 Obesity as a Global Medical Director. After a couple of years Claus decided to continue his career within a smaller pharmaceutical company.
Jeppe joined the programme after working in the clinic and several
years of research within inflammation and cardiovascular disease
resulting in a PhD degree. He worked as an International Medical
Director within Global Development in one of the key focus areas in
Novo Nordisk working on new generation of GLP-1RAs and then has been
appointed Senior Director in Medical & Science, Semaglutide
Diabetes & Diabetes Outcomes.
The 2008 PMP participants were Charlotte, Britt and Katja.
Charlotte, who prior to the programme worked and researched within obstetrics and gynaecology where she achieved a PhD degree, became an International Medical Director within Global Development in one of the key focus areas in Novo Nordisk working on the new generation of insulins.
Katja, who had previously been engaged in research within the field
of Neurology, became a Global Medical Advisor within Global Medical
Affairs. After some years in Novo Nordisk, Katja has returned to
pursuing a clinical career.
Britt, who before joining Novo Nordisk had started her specialist training as a General Practitioner within the public healthcare system, joined Global Safety as a Safety Surveillance Advisor after finishing the programme. In 2012 she was appointed Team Leader in Safety Surveillance and then has become Principal Specialist.
In 2007 the PMP team included of Marek, Troels and David.
Marek, who previously worked and researched within endocrinology, became an International Medical Director and worked in Global Development, M&S, Insulin & Digital Health for a number of years. Afterwards, he decided to continue his career within another pharmaceutical company.
Troels, who previously worked and researched within the areas of thoracic and abdominal surgery, became a Global Medical Advisor within Medical Affairs. Troels worked the first years within GLP-1 Diabetes and was later promoted to Senior Global Medical Advisor. Troels held a position as the Head of Medical Affairs in Novo Nordisk UK and Ireland for a number of years before returning to headquarters as Senior Global Medical Director within Medical Affairs. Troels is now Vice President in Medical and Scientific Affairs in the European office of Novo Nordisk.
Last, but not least David, who had his internship in New York, US, where he also did research focusing on cardiovascular diseases, became an International Medical Director within Global Development and hereafter a Global Medical Advisor. After several years with Novo Nordisk, David has chosen to pursue a career as an endocrinologist and has returned to clinical training.
In 2006 the PMP team included Trine and Yan.
Trine who previously worked within internal medicine moved on to a position as International Medical Director within Global Development and has since been working in key projects of new generation insulin and GLP-1 and obesity respectively.
Yan moved on to a position as Global Medical Advisor within Medical Affairs. After some time she decided to move out of Denmark and is no longer employed with Novo Nordisk.
With three rotations over two years, the PMP offers medical doctors a spring board to a life-changing career.
What is the PMP?